- Home
- IVVD vs SRTS Comparison
IVVD vs SRTS Comparison
Compare IVVD & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IVVD | SRTS |
|---|---|---|
| Founded | 2020 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 219.9M | 48.9M |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | IVVD | SRTS |
|---|---|---|
| Price | $0.95 | $2.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $8.75 | $7.00 |
| AVG Volume (30 Days) | ★ 4.7M | 33.9K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 79.02 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $53,426,000.00 | $27,482,000.00 |
| Revenue This Year | $61.57 | $2.00 |
| Revenue Next Year | $41.42 | $34.23 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 110.47 | N/A |
| 52 Week Low | $0.53 | $2.66 |
| 52 Week High | $3.07 | $5.49 |
Technical Indicators
Market Signals| Indicator | IVVD | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 56.99 | 41.10 |
| Support Level | $0.72 | $2.97 |
| Resistance Level | $1.02 | $3.30 |
| Average True Range (ATR) | 0.08 | 0.10 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 65.12 | 13.22 |
Price Performance
Historical ComparisonAbout IVVD Invivyd Inc.
Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.